Get the Stockscreener App
26.62
2.38%
-0.72
Staar Surgical Co stock is traded at $26.62, with a volume of 509.10K.
It is down -2.38% in the last 24 hours and down -11.00% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
See More
Previous Close:
$27.34
Open:
$27.34
24h Volume:
509.10K
Relative Volume:
0.55
Market Cap:
$1.33B
Revenue:
$290.38M
Net Income/Loss:
$-21.03M
P/E Ratio:
-61.99
EPS:
-0.4294
Net Cash Flow:
$-54.99M
1W Performance:
-6.97%
1M Performance:
-11.00%
6M Performance:
+20.28%
1Y Performance:
+60.69%
1-Day Range:
$25.89
$27.41
1-Week Range:
$25.89
$29.10
52-Week Range:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
26.65 | 1.36B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
426.08 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.25 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.97 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.11 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.78 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-03-26 | Initiated | Wedbush | Neutral |
| Jan-16-26 | Resumed | Morgan Stanley | Underweight |
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth - AD HOC NEWS
3 Reasons to Avoid STAA and 1 Stock to Buy Instead - Yahoo Finance
STAAR SURGICAL CO (STAA) Stock Chart - ChartMill
STAAR Surgical clears a key FDA milestone, shares in the medical device sector spotlight - AD HOC NEWS
STAAR Surgical (STAA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Form 4 STAAR Surgical Company For: 23 June By Investing.com - Investing.com Australia
5 must-read analyst questions from STAAR Surgical’s Q1 earnings call - MSN
Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options - Stock Titan
Form 4 STAAR Surgical Company For: 22 June By Investing.com - Investing.com Nigeria
STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike - Stock Titan
Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options - Stock Titan
STAAR Surgical (NASDAQ: STAA) director adds shares and options in equity grants - Stock Titan
STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO - Stock Titan
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
STAAR Surgical (STAA) director Jiang Wei exercises RSUs and receives new grant - Stock Titan
STAAR Surgical (STAA) director awarded RSUs and exercises prior units - Stock Titan
STAAR Surgical StockAnalyst views and long-term growth drivers - Ad-hoc-news.de
STAAR Surgical Co (STAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STAAR Surgical Co (STAA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
STAAR Surgical Co (STAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
STAAR Surgical Co (STAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
STAAR Surgical Co (STAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
STAAR Surgical Co (STAA) Institutional Confidence - TradingKey
STAAR Surgical Co (STAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
STAAR Surgical Co (STAA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
STAAR Surgical Co (STAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is STAAR Surgical Regaining Market Momentum? - Kalkine Media
STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple - simplywall.st
Director Lilian Zhou of STAAR Surgical (STAA) receives 3,530-share stock award - Stock Titan
Medical Devices & SuppliesSpecialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders - Yahoo Finance
STAAR Surgical Raises Pay for Interim Co-CEO Andrews - The Globe and Mail
STAAR appoints Deborah Andrews as Interim Co-CEO and CFO with pay increase - TradingView
STAAR Surgical (STAA) boosts interim co-CEO and CFO Deborah Andrews’ salary and bonus - Stock Titan
CenterBook Partners LP Buys New Position in STAAR Surgical Company $STAA - MarketBeat
STAA News | STAAR SURGICAL CO (NASDAQ:STAA) - ChartMill
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore - Yahoo Finance
How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets - Yahoo Finance
Midday Stock Roundup: TTM, Western Technology Up - Orange County Business Journal
STAAR Surgical Stock Hits Day Low of $29.03 Amid Price Pressure - MarketsMojo
Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors. - The Motley Fool
Staar Surgical Q1 Signals Potential Turnaround - Orange County Business Journal
STAAR Surgical Co stock (US8577001096): shares consolidate after Q1-driven jump on Nasdaq - AD HOC NEWS
STAAStaar Surgical Co Short Interest - Finviz
STAA Reiterated by Wedbush -- Price Target Maintained at $40 - GuruFocus
Staar Surgical Co (STAA) Stock Down 7.3% -- Now Undervalued? GF Score: 81/100 - GuruFocus
STAAR Surgical Co stock (US8577001096): shares softer after recent earnings jump and ongoing volatil - AD HOC NEWS
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SILVERMAN LOU | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
11,158 |
| Jiang Wei | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
77,127 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 14 '26 |
Option Exercise |
0.00 |
29,325 |
0 |
63,588 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
2.39%
2.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):